ZEAL moves to new headquarters

Article

ZEAL Optics has relocated its corporate headquarters to a space in historic downtown Bolder, CO, the company announced

Boulder, CO-ZEAL Optics has relocated its corporate headquarters to a space in historic downtown Bolder, CO, the company announced.

The community in which ZEAL now calls home matches the company’s eco-conscious values. Most of the town bikes to work, hits the rooftop bars for happy hour and will always be seen running, hiking or rock climbing on the weekends.

In the midst of this, ZEAL reports it has created an environment that is vibrant and promotes open thinking and that will affect how the company develops new markets, provides services for retailers, and connects with customers, said John Sanchez, president.

ZEAL has committed itself to reducing its carbon footprint through innovative manufacturing processes. It is the only sunglass brand made from a plant-based resin. In line with its environmentally conscious culture, the renovated offices--a building that has existed in Boulder since 1898 and is the former home to the W.W. Wolf’s Meat Market--uses locally obtained beetle-kill wood materials for construction.

“We are very excited to be Boulder-based as we craft our future lines,” said Joe Prebich, director of marketing. “It is more important than ever to have real, strong roots in what makes us who we are! It's going to be a great ride!”

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.